Article Text

This article has a correction. Please see:

Download PDFPDF
Susac’s syndrome: effective combination of immunosuppression and antiplatelet treatment
  1. I Kleffner1,
  2. E B Ringelstein1,
  3. P Young1,
  4. N Stupp2,
  5. T-U Niederstadt3
  1. 1Department of Neurology, University of Muenster, Muenster, Germany
  2. 2Department of Ophthalmology, University of Muenster
  3. 3Department of Radiology, University of Muenster
  1. Correspondence to:
 I Kleffner
 Department of Neurology, University of Muenster, Albert-Schweitzer-Str. 33, 48129 Muenster, Germany;kleffnil{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Susac’s syndrome is a rare disease predominantly affecting young women. The syndrome is characterised by the triad of encephalopathy, branch retinal artery occlusions (BRAO) and hearing loss.1–3 An inflammatory or vascular background, or both, for this small vessel disease is controversially discussed. Therapeutic options are rare.

A 17-year-old girl without a remarkable medical history presented with several episodes …

View Full Text


  • Competing interests: None declared.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd